Antisense Therapeutics
A timely primer on the new reality of antisense and RNA inhibition for treating a broad range of diseases. The authors show how antisense oligonucleotides are being designed and studied in relation to hypertension, various cancers, inflammatory bowel disease, brain disorders, the blood-brain barrier, and drug delivery. Highlights include RNA-based therapies for many diseases, up-to-date methods and applications, and insight into the enormous potential to provide a new generation of drugs.
CHF 240.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V105:
Folgt in ca. 15 Arbeitstagen
Produktdetails
- ISBN: 978-1-58829-205-6
- EAN: 9781588292056
- Produktnummer: 1776234
- Verlag: Springer Nature
- Sprache: Englisch
- Erscheinungsjahr: 2004
- Seitenangabe: 344 S.
- Masse: H23.7 cm x B16.3 cm x D2.6 cm 662 g
- Auflage: 2. A.
- Reihenbandnummer: 106
- Gewicht: 662
3 weitere Werke von M. Ian (Hrsg.) Phillips:
Recent Advances in Cellular and Molecular Aspects of Angiotensin Receptors
Ebook (PDF Format)
CHF 141.50
Bewertungen
Anmelden